# V34 Queue: Deepen Exploratory Shortlist and Fix Two-Lineage Generation

Session start UTC: 2026-06-07T16:02:33Z

## Live Queue

- [completed] Record real UTC start time and verify OpenGWAS / SAP credential
  presence.
- [completed] Phase 0: diagnose Gemini generation truncation and fix if
  possible.
- [completed] Phase 1: two-lineage cross-check of V33 shortlist if Gemini
  generation is fixed.
- [completed] Phase 2: deepen postpartum HLA-II/CD64 APC split first, then
  lysosomal APC bottleneck / complement-lipid axis as time permits.
- [in_progress] Phase 3: write `HYPOTHESIS_SLATE_V34.md`, update resume state,
  rebuild RAG, commit.

## Timing Discipline

Runtime for this session must use the real clock. Start timestamp above was
captured by `date -u` at session start. At session end, run `date -u` again and
derive elapsed wall-clock time from these two clock reads.

## Result

- Gemini generation bug fixed: client now detects `MAX_TOKENS` / `LENGTH` finish
  reasons and refuses to write silent partial output; high-token Gemini short
  generation produced parseable JSON.
- Two-lineage cross-check ran. Claude and Gemini both ranked MS-SLE EBV/IFN APC
  imprint first, but that hypothesis remains data-limited locally. Postpartum
  HLA-II/CD64 remains the best locally grounded and clinically anchored
  hypothesis.
- Postpartum deepening completed: existing RA/SLE/healthy pregnancy data support
  HLA-II-minus-CD64 as a postpartum trajectory state, but component behavior is
  heterogeneous by disease; the MS test must measure HLA-II and CD64 separately
  and link trajectory to postpartum relapse timing.

## Next Actions

1. Search/acquire postpartum MS relapse-timing blood/CSF immune data with DMT,
   steroid, lactation, infection, and cell-count metadata.
2. Build an EBV/LMP1/EBNA-response module and test separability from STAT1/IFN
   and V22 scalar in MS/SLE B-cell/APC data.
3. Mine progressive/chronic-active lesion data for complement/lipid negative
   pole orthogonality to V22 APC/HLA-II scalar.
